Guidance for industry : S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals.

Other author Center for Drug Evaluation and Research (U.S.)
Other author Center for Biologics Evaluation and Research (U.S.)
Other author International Conference on Harmonisation.
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [1997]
Descriptioni, 11 p. : digital, PDF file
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS114406
Subjects

Portion of title S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals
General noteTitle from PDF title page (viewed on July 7, 2009).
General note"ICH".
General note"July 1997".
General noteGPO Cataloging Record Distribution Program (CRDP).
Technical detailsMode of access: Internet at the FDA web site. Address as of 7/7/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129171.pdf ; current access is available via PURL.
GPO item number0499-T (online)
Govt. docs number HE 20.4702:SA 1/3